REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 52 filers reported holding REATA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $16,762,000 | +900.1% | 196,120 | +556.6% | 0.01% | +1100.0% |
| Q4 2018 | $1,676,000 | -67.4% | 29,870 | -52.4% | 0.00% | -50.0% |
| Q3 2018 | $5,134,000 | +382.1% | 62,798 | +106.3% | 0.00% | +100.0% |
| Q2 2018 | $1,065,000 | +114.3% | 30,443 | +25.5% | 0.00% | – |
| Q1 2018 | $497,000 | -33.1% | 24,248 | -7.6% | 0.00% | – |
| Q4 2017 | $743,000 | -12.9% | 26,248 | -4.3% | 0.00% | -100.0% |
| Q3 2017 | $853,000 | +17.0% | 27,431 | +19.1% | 0.00% | 0.0% |
| Q2 2017 | $729,000 | +94.9% | 23,041 | +39.6% | 0.00% | – |
| Q1 2017 | $374,000 | +1.4% | 16,500 | -2.4% | 0.00% | – |
| Q4 2016 | $369,000 | -25.8% | 16,914 | -10.3% | 0.00% | – |
| Q3 2016 | $497,000 | +33.6% | 18,855 | 0.0% | 0.00% | – |
| Q2 2016 | $372,000 | – | 18,855 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |